Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067
Shen Shen(Capital Medical University), Zhenfeng Duan(University of Miami)
Cited by 24
Related Papers
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
|Nature Medicine|2019|708
Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
|Oncotarget|2017|208
Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
|BMC Cancer|2009|161